Andrew Nicolaides Selected Research

Andrew Nicolaides Research Topics

Disease

9	Atherosclerosis 10/2023 - 04/2008
8	Stroke (Strokes) 10/2023 - 08/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 01/2009
4	COVID-19 06/2022 - 01/2020
3	Chronic Renal Insufficiency 11/2020 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2017
3	Hypertension (High Blood Pressure) 01/2020 - 01/2019
2	Pain (Aches) 10/2022 - 10/2021
2	Carotid Stenosis (Carotid Artery Stenosis) 09/2010 - 09/2010
1	Edema (Dropsy) 12/2023
1	Carotid Artery Diseases 11/2022
1	Hemorrhage 01/2022
1	Venous Thromboembolism 01/2022
1	Ulcer 10/2021
1	Hepatolenticular Degeneration (Wilson's Disease) 03/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Lymphatic Diseases 09/2020
1	Thrombosis (Thrombus) 01/2020
1	Ischemic Stroke 10/2019
1	Cerebral Small Vessel Diseases 09/2018
1	Coronary Disease (Coronary Heart Disease) 01/2017
1	Dyslipidemias (Dyslipidemia) 12/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015
1	Myocardial Infarction 03/2015
1	AIDS-Related Complex (ARC) 02/2015
1	Wounds and Injuries (Trauma) 03/2013
1	Atherosclerotic Plaque (Atheroma) 09/2009
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2008
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2004

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
4	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2015
3	CalciumIBA 10/2017 - 02/2015
3	LipidsIBA 12/2016 - 09/2010
2	FlavonoidsIBA 12/2023 - 10/2022
2	mesoglycanIBA 10/2023 - 06/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2021 - 01/2019
1	VaccinesIBA 05/2022
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2021
1	Calcium DobesilateIBA 10/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 10/2021
1	CopperIBA 03/2021
1	cupric sulfide (CuS)IBA 01/2020
1	ORALIT (ORS)IBA 10/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	LDL CholesterolIBA 01/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	PCSK9 InhibitorsIBA 01/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2016
1	Progesterone FDA LinkGeneric 09/2009
1	5,10-methylenetetrahydrofolic acidIBA 01/2009
1	HomocysteineIBA 01/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009
1	Oxidoreductases (Dehydrogenase)IBA 01/2009
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2008
1	Insulin-Like Growth Factor Binding Protein 3IBA 04/2008
1	Insulin-Like PeptidesIBA 04/2008
1	Insulin-Like Growth Factor Binding ProteinsIBA 04/2008
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2008
1	Warfarin (Coumadin)FDA LinkGeneric 02/2004
1	Tinzaparin (Innohep)FDA Link 02/2004
1	Heparin (Liquaemin)FDA LinkGeneric 02/2004

Therapy/Procedure

4	Therapeutics 01/2022 - 09/2010
4	Vascular Surgical Procedures 09/2020 - 09/2010
2	Secondary Prevention 09/2010 - 09/2010
1	Cognitive Training 03/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Percutaneous Coronary Intervention 05/2015
1	Catheters 02/2015
1	Orthopedic Procedures 03/2013
1	Carotid Endarterectomy 08/2011